Sylwia Stefanczyk

5PUBLICATIONS
14CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 19, 2026
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3).

Sylwia A Stefańczyk, Xenija Kaiser, Ilona Hagelstein

|Jul 13, 2024
Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia.

Sylwia A Stefańczyk, Clara Hayn, Jonas Heitmann

|Apr 18, 2024
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody.

Sylwia A Stefańczyk, Ilona Hagelstein, Martina S Lutz

|Mar 19, 2020
Novel Resolution Mediators of Severe Systemic Inflammation.

Verena Gudernatsch, Sylwia Anna Stefańczyk, Valbona Mirakaj

|Aug 02, 2019
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.

Tatsuya Morishima, Ann-Christin Krahl, Masoud Nasri

Pageof 1

Frequent Collaborators

3 joint publications

Melanie Märklin

2 joint publications

Samuel J Holzmayer

1 joint publications

Clara Hayn

1 joint publications

Latifa Zekri